Canada Pension Plan Investment Board Takes Position in Sotera Health (NASDAQ:SHC)

Canada Pension Plan Investment Board acquired a new position in shares of Sotera Health (NASDAQ:SHC) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 20,900 shares of the company’s stock, valued at approximately $248,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. CWM LLC lifted its position in Sotera Health by 86.1% during the 2nd quarter. CWM LLC now owns 2,146 shares of the company’s stock worth $25,000 after buying an additional 993 shares in the last quarter. Acadian Asset Management LLC raised its holdings in Sotera Health by 728.0% during the second quarter. Acadian Asset Management LLC now owns 9,381 shares of the company’s stock worth $111,000 after acquiring an additional 8,248 shares in the last quarter. Sandia Investment Management LP acquired a new position in Sotera Health during the first quarter valued at approximately $120,000. Securian Asset Management Inc. grew its stake in Sotera Health by 23.0% in the first quarter. Securian Asset Management Inc. now owns 10,178 shares of the company’s stock valued at $122,000 after purchasing an additional 1,900 shares in the last quarter. Finally, Wedmont Private Capital acquired a new position in shares of Sotera Health during the 2nd quarter worth approximately $127,000. Institutional investors and hedge funds own 91.03% of the company’s stock.

Insider Activity at Sotera Health

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the stock in a transaction on Friday, September 6th. The stock was sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the transaction, the director now owns 49,215,301 shares in the company, valued at approximately $739,705,974.03. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 55.12% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the company. Barclays increased their price objective on Sotera Health from $14.00 to $17.00 and gave the company an “overweight” rating in a report on Tuesday, August 6th. Royal Bank of Canada reissued an “outperform” rating and issued a $17.00 price objective on shares of Sotera Health in a research report on Tuesday, August 6th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $15.70.

Sotera Health Stock Performance

NASDAQ SHC opened at $16.76 on Friday. The stock has a market cap of $4.75 billion, a PE ratio of 88.22 and a beta of 2.07. The company has a debt-to-equity ratio of 5.46, a quick ratio of 2.59 and a current ratio of 2.93. The firm has a 50-day moving average of $15.24 and a 200-day moving average of $12.94. Sotera Health has a 52-week low of $10.71 and a 52-week high of $17.44.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings data on Monday, August 5th. The company reported $0.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.15 by $0.04. Sotera Health had a return on equity of 47.26% and a net margin of 3.65%. The company had revenue of $277.00 million during the quarter, compared to analysts’ expectations of $266.45 million. During the same quarter in the previous year, the company posted $0.19 earnings per share. The business’s revenue was up 8.6% on a year-over-year basis. On average, sell-side analysts anticipate that Sotera Health will post 0.64 EPS for the current year.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.